$AZN.L News and Market Events
Every $AZN.L story Market Flux has tracked.
- Market Flux Event
Myriad Genetics and SOPHiA GENETICS Team Up With AstraZeneca to Develop Prostate Cancer Genomic Instability Score Technology
Myriad Genetics and SOPHiA GENETICS announced on October 8, 2026 a new collaboration to develop and advance prostate cancer-specific genomic instability score (PrGIS) technology, with…
- Top Mover
Leerink Partners Cuts Bristol-Myers Squibb to Market Perform, Slashes Price Target to $59 on Pipeline Doubt
Leerink Partners downgraded Bristol-Myers Squibb from Outperform to Market Perform on October 5, cutting its price target to $59 from $73. Analyst David Risinger cited growing skepticism…
- Market Flux Event
FDA Grants Accelerated Approval to AstraZeneca's Breast Cancer Pill Etcamah for ESR1-Mutated Tumors
The U.S. Food and Drug Administration has granted accelerated approval to AstraZeneca's camizestrant, branded as Etcamah, for the treatment of hormone receptor-positive, HER2-negative…
- Market Flux Event
FDA Expands Mounjaro Label to Reduce Heart Attack and Stroke Risk in Type 2 Diabetes Patients
The FDA approved an expanded label for Eli Lilly's Mounjaro (tirzepatide) to reduce major adverse cardiovascular events, including heart attack and stroke, in high-risk patients with type 2…